Skip to main content
TU
NYSE Technology

TELUS Posts C$660M Q3 Loss, Launches C$900M Efficiency Program and Adds Board Members

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Telecom Stocks · Communication
Sentiment info
Negative
Importance info
7
Price
$9.07
Mkt Cap
$14.968B
52W Low
$7.64
52W High
$14.95
52W Position info
19% above low
Off High info
39% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

TU sits 19% above its 52-week low of $7.64.

Summary

TELUS reported a C$660 million Q3 net loss on an C$800 million non-cash TELUS Health impairment, pairing it with a new efficiency program targeting about C$900 million in annualized savings by 2028 and an accelerated sale process for non-core health and agriculture assets.


Key Events · Earnings and Guidance · TU

  • Q3 Net Loss on Health Impairment

    Net loss of C$660 million (basic loss per share C$0.42) versus net income of C$431 million a year earlier, driven by an C$800 million pre-tax non-cash goodwill impairment at TELUS Health.

  • C$900M Efficiency Program Launched

    The multi-year program targets approximately C$900 million in annualized cash savings exiting 2028, with about 80% from core Telecom and the balance from Global Platform Businesses.

  • Non-Core Asset Sales Accelerated

    Near-term priority is monetizing TELUS Health and TELUS Agriculture & Consumer Goods, with proceeds directed to debt reduction.

  • Leverage Above Target Range

    Net debt to Adjusted EBITDA was 3.6x at September 30, 2026, outside the 2.5-3.0x objective and against a 4.25x credit facility covenant; management targets 3.0x or lower by year-end 2028.


Analysis · TU · Technology

The headline is a C$660 million net loss (C$0.42 per share), driven by an C$800 million non-cash goodwill impairment at TELUS Health. But the more consequential news is the balance-sheet fix: a multi-year efficiency program targeting roughly C$900 million in annualized cash savings exiting 2028, an accelerated push to sell TELUS Health and TELUS Agriculture & Consumer Goods, and a board refresh. Leverage stands at 3.6x Adjusted EBITDA against a 2.5-3.0x target and a 4.25x covenant, so the asset sales and cost cuts are what stand between the current dividend and the debt load. Adjusted EBITDA of C$1.76 billion fell 5% and free cash flow dropped 35% to C$396 million, which explains why management reaffirmed rather than raised guidance.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TU was trading at $9.07 on NYSE in the Technology sector, with a market capitalization of approximately $15B. The 52-week trading range was $7.64 to $14.95. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TU - Latest Insights

TU
Nov 16, 2026, 4:44 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $9.80
Real-time Price: $11.04 info
Change: +$1.24 (+13%) info
Market Cap: $17.608B info
TU
Nov 16, 2026, 1:17 PM EST
Source: Benzinga
Importance Score:
9
Price at Filing: $9.44
Real-time Price: $11.04 info
Change: +$1.60 (+17%) info
Market Cap: $17.608B info
TU
Nov 06, 2026, 6:45 AM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $9.42
Real-time Price: $11.04 info
Change: +$1.62 (+17%) info
Market Cap: $17.608B info
TU
Jul 31, 2026, 7:12 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $9.81
Real-time Price: $11.04 info
Change: +$1.23 (+13%) info
Market Cap: $17.608B info
TU
Jul 31, 2026, 6:45 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $10.76
Real-time Price: $11.04 info
Change: +$0.2797 (+3%) info
Market Cap: $17.608B info